• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Enfusion Announces Appointment of Chief Operating Officer

    11/20/23 8:15:00 AM ET
    $ENFN
    Computer Software: Prepackaged Software
    Technology
    Get the next $ENFN alert in real time by email

    Neal Pawar brings decades of experience as a financial services and technology leader to Enfusion, having previously served in executive and leadership roles at AQR Capital Management, D.E. Shaw, Deutsche Bank, and UBS Wealth Management

    Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of cloud-native software-as-a-service (SaaS) solutions for investment managers, announced today that it has appointed Neal Pawar to serve as Enfusion's Chief Operating Officer (COO) effective November 27, 2023.

    As Enfusion continues to accelerate its growth trajectory and reinforce its market leadership position, Mr. Pawar will play a key role in shaping the next phase of Enfusion's business strategy and establishing best in class operational management practices. He will focus on driving cross-functional innovation and collaboration that will enable Enfusion to optimize its business operations, scale technology and infrastructure, and ultimately take the client experience to a level unmatched by other solution providers.

    "Neal is an incredibly exciting and timely addition to Enfusion's leadership team," said Oleg Movchan, Chief Executive Officer of Enfusion. "His deep industry and leadership experience in scaling technology and engineering, product development, and business operations will be transformative for Enfusion as we enter our next stage of growth. Neal is uniquely qualified to be Enfusion's COO given his experience in commercializing software and data solutions supported by a rare blend of technology and operating expertise across traditional and alternative investment strategies, wealth management and investment banking. I look forward to partnering with Neal as we continue to scale the business and expand our market footprint with global enterprise clients within the institutional investment management space."

    Mr. Pawar has spent nearly 30 years in the financial services industry and has held a variety of leadership roles. Most recently, Mr. Pawar was the COO and later the CEO of Qontigo, a provider of financial intelligence tools and indices for investment managers. Prior to that, Mr. Pawar served as Group Chief Information Officer at Deutsche Bank, Principal and Chief Technology Officer at AQR Capital Management, Chief Information Officer at UBS Wealth Management, and Managing Director at D.E. Shaw. Mr. Pawar holds a B.S. in Computer Science from Brown University.

    "I'm thrilled to join Enfusion and looking forward to working closely with Oleg and many other individuals and teams across the organization to enable Enfusion's execution of its ambitious growth and innovation strategy," said Mr. Pawar. "As an engineer at heart, my operating roles have allowed me to lead and influence the way Institutional Investors harness investment software platforms. I am excited to bring this, as well as the experience I've gained operating a large, global SaaS business, to Enfusion."

    About Enfusion

    Enfusion's investment management software-as-a-service (SaaS) platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one cloud-native system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence, boosting agility, and powering growth. Enfusion partners with over 800 investment managers from 10 global offices spanning four continents.

    Forward-Looking Statements

    Statements we make in this press release may include statements which are not historical facts and are considered forward-looking within the meaning of Section 27A of the Securities Act of 1933 ("Securities Act") and Section 21E of the Securities Exchange Act of 1934 ("Exchange Act"), including expectations regarding future financial performance. These forward-looking statements are usually identified by the use of words such as "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "seeks," "should," "could," "will," and variations of such words or similar expressions. We intend these forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act and Section 21E of the Exchange Act and are making this statement for purposes of complying with those safe harbor provisions. These forward-looking statements reflect our current views about our plans, intentions, expectations, strategies and prospects, which are based on the information currently available to us and on assumptions we have made. Although we believe that our plans, intentions, expectations, strategies and prospects as reflected in or suggested by those forward-looking statements are reasonable, we can give no assurance that the plans, intentions, expectations or strategies will be attained or achieved. Furthermore, actual results may differ materially from those described in the forward-looking statements and will be affected by a variety of risks and factors that are beyond our control, such as those set forth in our Annual Report on Form 10-K for the fiscal year ended December 31, 2022 that was filed with the Securities and Exchange Commission ("SEC") on March 10, 2023, our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 that was filed with the SEC on May 9, 2023, our Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 that was filed with the SEC on August 8, 2023, and our Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023 that was filed with the SEC on November 7, 2023. We assume no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

    Source: Enfusion, Inc.

    Source Code: ENFN-IR

    View source version on businesswire.com: https://www.businesswire.com/news/home/20231120442326/en/

    Get the next $ENFN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ENFN

    DatePrice TargetRatingAnalyst
    5/10/2024$11.00Overweight
    Morgan Stanley
    2/28/2024$9.00 → $8.00Neutral → Sell
    Goldman
    1/30/2024$11.00 → $9.00Neutral → Underweight
    JP Morgan
    11/7/2023$9.00Neutral
    UBS
    4/3/2023$11.00Neutral
    Piper Sandler
    3/15/2023$12.00Neutral
    JP Morgan
    1/4/2023$15.00 → $10.00Neutral → Underperform
    BofA Securities
    1/3/2023$13.00 → $12.00Equal-Weight → Overweight
    Morgan Stanley
    More analyst ratings

    $ENFN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Iconiq Strategic Partners V, L.P. disposed of 9,009,594 shares (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:12 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Director Luo Roy returned 9,009,594 shares to the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/23/25 4:30:09 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Chief Operating Officer Pawar Neal returned 1,217,308 shares to the company, closing all direct ownership in the company (SEC Form 4)

      4 - Enfusion, Inc. (0001868912) (Issuer)

      4/21/25 5:11:16 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    SEC Filings

    See more
    • SEC Form 15-12G filed by Enfusion Inc.

      15-12G - Enfusion, Inc. (0001868912) (Filer)

      5/1/25 4:15:29 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form EFFECT filed by Enfusion Inc.

      EFFECT - Enfusion, Inc. (0001868912) (Filer)

      4/24/25 12:15:09 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • SEC Form POS AM filed by Enfusion Inc.

      POS AM - Enfusion, Inc. (0001868912) (Filer)

      4/21/25 4:57:41 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Financials

    Live finance-specific insights

    See more
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion Announces Fourth Quarter and Full Year 2024 Results

      Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Total revenue was $52.9 million, up 13.9% compared to the same period in the prior year. Gross Profit was $36.5 million with a Gross Profit Margin of 69.0%. Adjusted Gross Profit was $36.9 million with an Adjusted Gross Profit Margin of 69.6%. Net Income was $0.2 million with a Net Income Margin of 0.3%. Adjusted EBITDA was $12.3 million, up 25.3% compared to the same period in the prior year. Operating Cash Fl

      3/3/25 4:05:00 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities

      Investor Conference Call Scheduled for Today at 8:30 a.m. ET Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry. The purchase price is $11.25 per share, delivered in an approximately equal mix of cash and stock. Additionally, Clearwater will pay $30 million to terminate Enfusion's tax receivable agreement (TRA). This equates to a purchase price of approximately $1.5 billion. This press release features multimedia. View the full release here: https

      1/13/25 6:30:00 AM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • OPENLANE Names Brad Herring Chief Financial Officer

      Bolsters Leadership Bench With More Than 30 Years of Financial Management and Investor Relations Expertise CARMEL, Ind., April 22, 2025 /PRNewswire/ -- OPENLANE, Inc. (NYSE:KAR), a leading operator of digital marketplaces for wholesale used vehicles, announces the company has named Brad Herring as EVP and Chief Financial Officer effective May 27, 2025. Herring will be responsible for leading all financial, reporting and investor-facing functions across OPENLANE, including the company's capital investment strategy. Herring also joins OPENLANE's executive team and will report to CEO Peter Kelly.

      4/22/25 4:15:00 PM ET
      $ENFN
      $FOUR
      $KAR
      Computer Software: Prepackaged Software
      Technology
      Business Services
      Consumer Discretionary
    • Clearwater Analytics Finalizes Acquisition of Enfusion

      Clearwater Will Deliver Industry's First Unified, Cloud-Native Front-to-Back Platform for Institutional Investors Clearwater Analytics (NYSE:CWAN), the most comprehensive technology platform for investment management, today announced the successful completion of its acquisition of Enfusion, Inc. (NYSE:ENFN), a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund sectors, in a deal valued at approximately $1.5 billion. This strategic combination positions Clearwater as the industry's first single-instance, multi-tenant, cloud-native platform to unify front, middle, and back-office investment operations. By integrating portfolio and order management,

      4/21/25 4:15:00 PM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Clearwater Analytics and Enfusion Announce Preliminary Results of Election by Enfusion Shareholders Regarding Form of Merger Consideration

      Clearwater Analytics (NYSE:CWAN) ("Clearwater") and Enfusion, Inc. (NYSE:ENFN) ("Enfusion") today announced the preliminary results of the elections made by Enfusion shareholders of record regarding the form of merger consideration (the "Merger Consideration") they wish to receive in connection with Clearwater's acquisition of Enfusion (the "Transaction"). As previously disclosed, the deadline to have made such an election was 5:00 p.m. Eastern Time on April 16, 2025 (the "Election Deadline"). The parties expect to close the Transaction on April 21, 2025, subject to the approval of the Transaction by Enfusion shareholders and the satisfaction or waiver of other customary closing conditions

      4/17/25 8:00:00 AM ET
      $CWAN
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      10/29/24 7:13:25 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      10/25/24 4:30:55 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Amendment: SEC Form SC 13G/A filed by Enfusion Inc.

      SC 13G/A - Enfusion, Inc. (0001868912) (Subject)

      9/6/24 3:32:03 PM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology

    $ENFN
    Leadership Updates

    Live Leadership Updates

    See more
    • FTV Capital Named to Inc.'s Founder-Friendly Investors List for Fourth Consecutive Year

      FTV Capital, a leading sector-focused growth equity investment firm, today announced its inclusion for the fourth consecutive year on Inc.'s annual Founder-Friendly Investors list, which honors the private equity, venture capital firms and lenders with a track record of backing founder-led companies. This year's list recognizes 269 firms that believe in backing founder-led businesses and helping them thrive, demonstrated by their successful track records of collaboration and remaining actively involved with their portfolio companies to drive growth. "We are honored to be recognized again by Inc. for our ongoing commitment to serving as a collaborative, strategic partner to founders and ent

      10/29/24 7:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services
    • Enfusion Announces Key Leadership Team Additions to Drive Client Success and Fuel Innovation

      Appointments of Arman Artuc to Head of Engineering, and Jesper Cordes to Head of Client Services Americas, Will Further Elevate Enfusion's Operations as an Investment Technology Industry Leader Enfusion, Inc. ("Enfusion") (NYSE:ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, announced today the appointments of Arman Artuc to Head of Engineering and Jesper Cordes to Head of Client Services Americas. These additions to the leadership team reinforce the company's position as a global leader in investment technology and services, which enables Enfusion to continue to attract top-performing industry experts and innovators to its ranks. Enfusion is s

      10/10/24 9:00:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • ZEMA Global Data Corporation to Acquire Morningstar Commodity Data

      Transformative acquisition will position ZEMA as global leader in offering high-quality enterprise data management and analytics for the energy and commodities industry ZEMA Global Data Corporation (formerly ZE PowerGroup), a leading provider of enterprise data management and analytics for the commodity and energy sectors, today announced its plans to acquire Morningstar Commodity Data, a provider of commodities and energy data and insights. The transaction is expected to close later this month. The business will serve a diverse portfolio of over 200 enterprises with an expanded product offering and broader geographic operations to support customers around the world. The announcement come

      9/23/24 8:00:00 AM ET
      $ENFN
      $GLOB
      Computer Software: Prepackaged Software
      Technology
      EDP Services

    $ENFN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Morgan Stanley resumed coverage on Enfusion with a new price target

      Morgan Stanley resumed coverage of Enfusion with a rating of Overweight and set a new price target of $11.00

      5/10/24 8:40:24 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by Goldman with a new price target

      Goldman downgraded Enfusion from Neutral to Sell and set a new price target of $8.00 from $9.00 previously

      2/28/24 6:16:11 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology
    • Enfusion downgraded by JP Morgan with a new price target

      JP Morgan downgraded Enfusion from Neutral to Underweight and set a new price target of $9.00 from $11.00 previously

      1/30/24 6:55:00 AM ET
      $ENFN
      Computer Software: Prepackaged Software
      Technology